Cell Line, Tumor: A cell line derived from cultured tumor cells.Tumor Cells, Cultured: Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.Gingiva: Oral tissue surrounding and attached to TEETH.Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.Cell Line: Established cell cultures that have the potential to propagate indefinitely.Gene Expression Regulation, Neoplastic: Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.Mice, Nude: Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses.Neoplasm Proteins: Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.Periodontitis: Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology)Confidentiality: The privacy of information and its protection against unauthorized disclosure.NevadaMedical Laboratory Science: The specialty related to the performance of techniques in clinical pathology such as those in hematology, microbiology, and other general clinical laboratory applications.Medical Laboratory Personnel: Health care professionals, technicians, and assistants staffing LABORATORIES in research or health care facilities.Laboratory Infection: Accidentally acquired infection in laboratory workers.Laboratories: Facilities equipped to carry out investigative procedures.Laboratories, Hospital: Hospital facilities equipped to carry out investigative procedures.Pharmacopoeias as Topic: Authoritative treatises on drugs and preparations, their description, formulation, analytic composition, physical constants, main chemical properties used in identification, standards for strength, purity, and dosage, chemical tests for determining identity and purity, etc. They are usually published under governmental jurisdiction (e.g., USP, the United States Pharmacopoeia; BP, British Pharmacopoeia; P. Helv., the Swiss Pharmacopoeia). They differ from FORMULARIES in that they are far more complete: formularies tend to be mere listings of formulas and prescriptions.Physicians: Individuals licensed to practice medicine.Stomach Neoplasms: Tumors or cancer of the STOMACH.Mutation: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.Point Mutation: A mutation caused by the substitution of one nucleotide for another. This results in the DNA molecule having a change in a single base pair.Mutation, Missense: A mutation in which a codon is mutated to one directing the incorporation of a different amino acid. This substitution may result in an inactive or unstable product. (From A Dictionary of Genetics, King & Stansfield, 5th ed)Atlases as Topic: Collections of illustrative plates, charts, etc., usually with explanatory captions.Adenocarcinoma, Scirrhous: An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense connective tissue in the stroma. (From Dorland, 27th ed)Molecular Sequence Data: Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.Materia Medica: Materials or substances used in the composition of traditional medical remedies. The use of this term in MeSH was formerly restricted to historical articles or those concerned with traditional medicine, but it can also refer to homeopathic remedies. Nosodes are specific types of homeopathic remedies prepared from causal agents or disease products.Homeopathy: A system of therapeutics founded by Samuel Hahnemann (1755-1843), based on the Law of Similars where "like cures like". Diseases are treated by highly diluted substances that cause, in healthy persons, symptoms like those of the disease to be treated.Friction: Surface resistance to the relative motion of one body against the rubbing, sliding, rolling, or flowing of another with which it is in contact.Fibroadenoma: An adenoma containing fibrous tissue. It should be differentiated from ADENOFIBROMA which is a tumor composed of connective tissue (fibroma) containing glandular (adeno-) structures. (From Dorland, 27th ed)Arnica: A plant genus of the family ASTERACEAE. The dried flower heads of Arnica montana are used externally as a counterirritant and tincture for sprains and bruises, either as crude extract or in homeopathic dilution (HOMEOPATHY). Arnica contains volatile oils (OILS, VOLATILE), arnicin, arnisterol, FLAVONOIDS; TANNINS; and resin. The common name of Wolf's Bane is similar to the common name for ACONITUM.Skin: The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.Hemorrhoidectomy: The surgical removal of HEMORRHOIDS.Strychnos nux-vomica: A plant genus of the genus STRYCHNOS, family LOGANIACEAE that is the source of STRYCHNINE.Groin: The external junctural region between the lower part of the abdomen and the thigh.Hemorrhoids: Swollen veins in the lower part of the RECTUM or ANUS. Hemorrhoids can be inside the anus (internal), under the skin around the anus (external), or protruding from inside to outside of the anus. People with hemorrhoids may or may not exhibit symptoms which include bleeding, itching, and pain.Magnetic Resonance Imaging: Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.Ependyma: A thin membrane that lines the CEREBRAL VENTRICLES and the central canal of the SPINAL CORD.Neuroradiography: Radiography of the central nervous system.Brain: The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.Abscess: Accumulation of purulent material in tissues, organs, or circumscribed spaces, usually associated with signs of infection.Cerebral Ventriculitis: Inflammation of CEREBRAL VENTRICLES.Cysts: Any fluid-filled closed cavity or sac that is lined by an EPITHELIUM. Cysts can be of normal, abnormal, non-neoplastic, or neoplastic tissues.Diffusion Magnetic Resonance Imaging: A diagnostic technique that incorporates the measurement of molecular diffusion (such as water or metabolites) for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient (ADC) with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment.Cerebral Ventricles: Four CSF-filled (see CEREBROSPINAL FLUID) cavities within the cerebral hemispheres (LATERAL VENTRICLES), in the midline (THIRD VENTRICLE) and within the PONS and MEDULLA OBLONGATA (FOURTH VENTRICLE).Tomography, X-Ray Computed: Tomography using x-ray transmission and a computer algorithm to reconstruct the image.South CarolinaSulfonesPurines: A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.PiperazinesPhosphodiesterase Inhibitors: Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.Phosphodiesterase 5 Inhibitors: Compounds that specifically inhibit PHOSPHODIESTERASE 5.FloridaErectile Dysfunction: The inability in the male to have a PENILE ERECTION due to psychological or organ dysfunction.Indiana3',5'-Cyclic-GMP Phosphodiesterases: Enzymes that catalyze the hydrolysis of cyclic GMP to yield guanosine-5'-phosphate.
(1/66) Borrmann's type IV gastric cancer: clinicopathologic analysis.

OBJECTIVE: To determine whether there is a specific pattern of clinicopathological features that could distinguish Borrmann's type IV gastric cancer from other types of gastric cancer. DESIGN: A retrospective study of patients with advanced gastric cancer treated between 1985 and 1995. SETTING: The Department of Surgery, Sendai National Hospital, a 716-bed teaching hospital. PATIENTS: The clinicopathologic features of 88 patients with Borrmann's type IV carcinoma of the stomach were reviewed from the database of gastric cancer. The results were compared with those of 309 patients with other types of gastric carcinoma. MAIN OUTCOME MEASURES: Gender, age, tumour size, depth of invasion, histologic type, cancer-stromal relationship, histologic growth pattern, nodal involvement, lymphatic and vascular invasion, type of operation, cause of death and 5-year survival. RESULTS: Women were afflicted as commonly as men in the Borrmann's type IV group. These patients tended to be younger and to have larger tumours involving the entire stomach than patients with other types of cancer. Histologic type was commonly diffuse and scirrhous, and serosal invasion was prominent with infiltrative growth. Nodal involvement and lymphatic invasion were more common in patients with Borrmann's type IV than in those with other types of gastric cancer. The disease was advanced in most instances and a total gastrectomy was performed in 55% of the patients. The survival rate of patients with Borrmann's type IV tumour was lower than for patients with other types of gastric cancer (p < 0.005, log-rank test). CONCLUSIONS: In Borrmann's type IV gastric cancer, early detection and curative resection are crucial to extend the patient's survival. Aggressive postoperative chemotherapy is recommended when a noncurative resection is performed.  (+info)

(2/66) Scirrhous cancer of the stomach which survived for more than five years after neoadjuvant chemotherapy with UFT (uracil and tegafur) and cisplatin.

A 68-year-old man was diagnosed as having a scirrhous cancer of the stomach. Carcinomatous peritonitis was suspected on abdominal CT examination. Three courses of uracil and tegafur (UFT)/cisplatin (CDDP) chemotherapy were administered. The primary foci were reduced in size, then total gastrectomy was performed. Histological findings revealed a poorly differentiated adenocarcinoma with scirrhous invasion into the subserosa. Histological efficacy of the chemotherapy was judged to be grade 2. The patient has been alive without disease for more than five years after total gastrectomy. Neoadjuvant chemotherapy with UFT and CDDP may have contributed to the favorable clinical outcome in this patient.  (+info)

(3/66) Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

Scirrhous gastric cancer is often accompanied by metastasis to the peritoneum and/or lymph nodes, resulting in the highest mortality rate among gastric cancers. Mechanisms involved in gastric cancer metastasis are not fully clarified because metastasis involves multiple steps and requires the accumulation of altered expression of many different genes. Thus, independent analysis of any single gene would be insufficient to understand all of the aspects of gastric cancer metastasis. In this study, we performed global analysis on differential gene expression of a scirrhous gastric cancer cell line (OCUM-2M) and its derivative sublines with high potential for metastasis to the peritoneal cavity (OCUM-2MD3) and lymph nodes (OCUM-2MLN) in a nude mice model. By applying a high-density oligonucleotide array method, expression of approximately 6800 genes was analyzed, and selected genes were confirmed by the Northern blot method. In our observations in OCUM-2MD3 cells, 12 genes were up-regulated, and 20 genes were down-regulated. In OCUM-2MLN cells, five genes were up-regulated, and five genes were down-regulated. The analysis revealed two functional gene clusters with altered expression: (a) down-regulation of a cluster of squamous cell differentiation marker genes such as small proline-rich proteins [SPRRs (SPRR1A, SPRR1B, and SPRR2A], annexin A1, epithelial membrane protein 1, cellular retinoic acid-binding protein 2, and mesothelin in OCUM-2MD3 cells; and (b) up-regulation of a cluster of antigen-presenting genes such as MHC class II (DP, DR, and DM) and invariant chain (II) in OCUM-2MLN cells through up-regulation of CIITA (MHC class II transactivator). We then analyzed six gastric cancer cell lines by Northern blot and observed preferential up-regulation of trefoil factor 1, alpha-1-antitrypsin, and galectin 4 and down-regulation of cytidine deaminase in cells prone to peritoneal dissemination. Genes highly correlated with invasion or peritoneal dissemination of gastric cancer, such as E-cadherin or integrin beta4, were down-regulated in both of the derivative cell lines analyzed in this study. This is the first demonstration of global gene expression analysis of gastric cancer cells with different metastatic potentials, and these results provide a new insight in the study of human gastric cancer metastasis.  (+info)

(4/66) Invasion activating caveolin-1 mutation in human scirrhous breast cancers.

We looked for mutations in the caveolin-1 gene, encoding a critical molecule for membrane signaling to cell growth, in 92 primary human breast cancers, and we report here the identification of a mutation in caveolin-1 at codon 132 (P132L) in 16% of cases. The mutation-positive cases were mostly invasive scirrhous carcinomas. In cell lines expressing the same mutant of caveolin-1, we observed that the mutant Caveolin-1 expression seemed to induce cellular transformation and activation of mitogen-activated protein kinase-signaling pathway and to promote invasion-ability as well as altered actin networks in the cells. These results provide, for the first time, genetic evidence that a functioning Caveolin-1 mutation may have a role in the malignant progression of human breast cancer.  (+info)

(5/66) Intestinal perforation due to metastasis of breast carcinoma, with special reference to chemotherapy: a case report.

We report a case of small-bowel perforation due to metastatic carcinoma of the breast during chemotherapy. Partial resection of the small intestine and primary anastomosis were performed. Although the patient made a good recovery from panperitonitis, she died of the disease on the 55th postoperative day. Since perforation during chemotherapy results in an extremely poor prognosis, special caution during chemotherapy is needed for patients with possible gastrointestinal involvement with tumor.  (+info)

(6/66) A novel variant of WISP1 lacking a Von Willebrand type C module overexpressed in scirrhous gastric carcinoma.

Scirrhous carcinoma of the stomach is characterized by rapid growth with a vast fibrous stroma, high invasiveness, and substantially a poor prognosis. Little is known of the molecular pathogenesis of this disease. Members of the emerging family of the CCN gene (for connective tissue growth factor, cysteine-rich 61, nephroblastoma overexpressed) encode cysteine-rich secreted proteins with roles in human fibrotic disorders and cancer progression. Using targeted differential displays, we identified a novel variant of the CCN family member WISP1 (Wnt-induced secreted protein 1), named WISP1v, as overexpressed in scirrhous gastric carcinomas. Predicted protein of the WISP1v completely lacks a module of Von Willebrand type C that is thought to participate in protein complex formation. Ectopic expression revealed WISP1v to be a secreted oncoprotein inducing a striking cellular transformation and rapid piling-up growth. It is noteworthy that WISP1v transfectants enhanced the invasive phenotype of co-cultured gastric carcinoma cells, while wild-type WISP1 had no such potential. These findings suggest that CCN protein WISP1v is involved in the aggressive progression of scirrhous gastric carcinoma.  (+info)

(7/66) Detection method and breast carcinoma histology.

BACKGROUND: The association between method of detection and breast carcinoma histopathology has not been assessed adequately in a population-based setting. METHODS: Among women who were included in a population-based, case-control study of breast cancer, patients who were newly diagnosed with invasive breast carcinoma were identified from Wisconsin's statewide tumor registry. Only women age > or = 50 years were analyzed, because screening by mammography was not recommended before age 50 years at the time of the study. The breast tumors among these women (n = 2341 tumors) included the following histopathologies: lobular carcinoma (n = 206 tumors); ductal carcinoma, not otherwise specified (n = 1920 tumors); papillary carcinoma (n = 15 tumors); medullary carcinoma (n = 36 tumors); mucinous adenocarcinoma (n = 56 tumors); tubular adenocarcinoma (n = 41 tumors); invasive comedocarcinoma (n = 24 tumors); scirrhous adenocarcinoma (n = 15 tumors); and mixed ductal/lobular carcinoma (n = 28 tumors). RESULTS: Overall, women reported that 41% of tumors were detected by mammography, 48% of tumors were self detected, and 11% of tumors were detected by clinical breast examination (CBE). Detection by mammography was significantly more likely for women who had tubular carcinoma (83%; P < 0.001) and invasive comedocarcinoma (67%; P = 0.23) compared with women who had ductal carcinoma (40%). Mammography was significantly less likely to detect medullary carcinoma (17%) than ductal carcinoma (40%; P = 0.01). Lobular carcinoma was the only histopathology that, compared with ductal carcinoma, was detected significantly more often by CBE than by self detection. Mammography detected lobular carcinoma (42%) as frequently as ductal carcinoma (40%). However, the use of postmenopausal hormones may have modified these detection patterns: Among current users, mammography discovered a greater percentage of ductal carcinomas (51%) and fewer lobular carcinomas (36%) than nonusers. CONCLUSIONS: Among women age > or = 50 years, breast cancer detection by mammography, self detection, and CBE varied according to tumor histopathology.  (+info)

(8/66) Scirrhous gastric carcinoma with mediastinal invasion in a dog.

An 8-year-old male Rottweiler was presented for recurrent episodes of dysphagia and vomiting with chronic weight loss. Radiography revealed a mediastinal mass in the heart base region. Necropsy revealed a firm, white mediastinal mass extending along the distal esophagus, through the diaphragm, to the gastric cardia, leftward to the convex visceral aspect of the fundus, and rightward along the lesser curvature of the stomach to the pyloric antrum. The gastric lymph node was enlarged and the omentum contained several nodules. Histologically, deep fundic mucosa contained pleomorphic, vacuolated cells with intracytoplasmic mucin, which was hyaluronidase resistant. Neoplastic cells were cytokeratin positive and vimentin negative. Transmural invasion was evidenced by the presence of cytokeratin-positive cells between smooth muscle bundles of the gastric wall. The mediastinal mass was composed of clusters of neoplastic cells in a stroma of dense and loose connective tissue. Neoplastic cells were also within blood and lymphatic vessels, tracheobronchial and gastric lymph nodes, and around peripheral nerves. This carcinoma most likely arose from the gastric fundus and extended to the cardia, from where it advanced proximally to the mediastinum as well as further rightward along the lesser curvature, demonstrating an anatomic continuity suggestive of a direct invasion. Metastasis, evidenced by the presence of lymphatic, blood, and perineural tumor emboli, also occurred.  (+info)

*  International Classification of Diseases for Oncology
Adenocarcinoma, NOS M8140/6 Adenocarcinoma, metastatic, NOS M8141/3 Scirrhous adenocarcinoma Scirrhous carcinoma Carcinoma with ... Basophil adenocarcinoma Mucoid cell adenocarcinoma M8310/0 Clear cell adenoma M8310/3 Clear cell adenocarcinoma, NOS Clear cell ... Parietal cell adenocarcinoma M8215/3 Adenocarcinoma of anal glands (C21.1) Adenocarcinoma of anal ducts M8220/0 Adenomatous ... NOS M8210/3 Adenocarcinoma in adeonmatous polyp Adenocarcinoma in tubular adenoma Carcinoma in adeomatous polyp Adenocarcinoma ...
*  List of MeSH codes (C04)
... adenocarcinoma, scirrhous MeSH C04.557.470. --- linitis plastica MeSH C04.557.470.200.025.105 --- adenocarcinoma ... adenocarcinoma, bronchiolo-alveolar MeSH C04.557.470.200.025.045 --- adenocarcinoma, clear cell MeSH C04.557.470.200.025.060 ... adenocarcinoma, mucinous MeSH C04.557.470.200.025.085 --- adenocarcinoma, papillary MeSH C04.557.470. --- ... adenocarcinoma, sebaceous MeSH C04.557.470.550.175 --- adenoma, sweat gland MeSH C04.557.470.550.175.125 --- acrospiroma, ...
*  Renal cell carcinoma
It is considered an adenocarcinoma. There are two subtypes: sporadic (that is, non-hereditary) and hereditary. Both such ... Koenig divided the tumors into scirrhous, steatomatous, fungoid and medullary forms. Following the classification of the tumour ...
*  Prostate cancer
The LNCaP cancer cell line was established from a human lymph node metastatic lesion of prostatic adenocarcinoma. PC-3 and DU- ... ISBN 0-8070-2200-4. Adams J (1853). "The case of scirrhous of the prostate gland with corresponding affliction of the lymphatic ... The region of prostate gland where the adenocarcinoma is most common is the peripheral zone. Initially, small clumps of cancer ... Prostate cancer is classified as an adenocarcinoma, or glandular cancer, that begins when normal semen-secreting prostate gland ...
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients - Full...  A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients - Full...
Adenocarcinoma. Stomach Neoplasms. Neoplasms by Site. Stomach Diseases. Linitis Plastica. Adenocarcinoma, Scirrhous. Neoplasms ... Adenocarcinoma, Scirrhous Linitis Plastica Stomach Neoplasms Stomach Diseases Neoplasms by Site Neoplasms Drug: TKI258 Phase 2 ... A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients. The ... Advanced scirrhous gastric carcinoma. Gastric Cancer. Second-line or third-line treatment. VEGF. FGFR. Neoplasms. Gastric ...
more infohttps://clinicaltrials.gov/ct2/show/NCT01576380?recr=Open&cond=%22Stomach+Neoplasms%22&rank=20
Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone  Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Adenocarcinoma, Scirrhous. An adenocarcinoma with a hard (Greek skirrhos, hard) structure owing to the formation of dense ... Adenocarcinoma, Follicular. An adenocarcinoma of the thyroid gland, in which the cells are arranged in the form of follicles. ( ... Adenocarcinoma In Situ. A lesion with cytological characteristics associated with invasive adenocarcinoma but the tumor cells ... Adenocarcinoma, Papillary. An adenocarcinoma containing finger-like processes of vascular connective tissue covered by ...
more infohttps://www.bioportfolio.com/resources/trial/73213/Continued-HER2-Suppression-With-Lapatinib-Plus-Trastuzumab-Versus-Trastuzumab-Alone.html
AYAKO TAKETOMI-TAKAHASI | Researcher Profile | Symptoma.com  AYAKO TAKETOMI-TAKAHASI | Researcher Profile | Symptoma.com
Scirrhous ❗ Breast Neoplasms ❗ Neovascularization, Pathologic ❗ Check More at Symptoma.com ... AYAKO TAKETOMI-TAKAHASI published 1 Research Articles on Adenocarcinoma, ... Adenocarcinoma, Scirrhous 2x. Breast Neoplasms 2x. Neovascularization, Pathologic Register to see all ... Perfusion CT of breast carcinoma: arterial perfusion of nonscirrhous carcinoma was higher than that of scirrhous carcinoma. ...
more infohttps://www.symptoma.com/en/research/profile/a_taketomi-takahasi
Molecular mechanism of stomach carcinogenesis.  - PubMed - NCBI  Molecular mechanism of stomach carcinogenesis. - PubMed - NCBI
Moreover, the K-sam gene is amplified preferentially in poorly differentiated adenocarcinoma of scirrhous carcinoma. K-sam ... Among them, those most commonly implicated in both well-differentiated adenocarcinoma and poorly differentiated adenocarcinoma ... LOH on chromosome 18q (DCC locus) and LOH of the bcl-2 gene also are common events of well-differentiated adenocarcinoma. LOH ... Conversely, the development of poorly differentiated adenocarcinoma, in addition to changes in p53 and c-met genes, requires ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/8440743?dopt=Abstract
Adenocarcinoma, metastatic. Scirrhous adenocarcinoma. Linitis plastica. Superficial spreading adenocarcinoma. Adenocarcinoma, ...
more infohttps://www.leg.state.nv.us/NAC/NAC-457.html
Cheng, Y. S.<...  Cheng, Y. S.<...
Scirrhous Adenocarcinoma Deformity of duodenal bulb, gastric metaplasia of duodenal regenerating mucosa and recurrence of ...
more infohttps://tmu.pure.elsevier.com/en/persons/yeong-shan-cheng
Plus it  Plus it
... this patient was a 64-year-old male whose gastric cancer had been diagnosed as a poorly differentiated scirrhous adenocarcinoma ... Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral ... and the one gastric cancer clinical sample with a MEK1 mutation was a poorly differentiated adenocarcinoma. Choi and colleagues ... these results suggest that gastric cancer with MEK1 mutations might be likely to have a poorly differentiated adenocarcinoma ...
more infohttp://mct.aacrjournals.org/content/13/12/3098
International Classification of Diseases for Oncology - Wikipedia  International Classification of Diseases for Oncology - Wikipedia
Adenocarcinoma, NOS M8140/6 Adenocarcinoma, metastatic, NOS M8141/3 Scirrhous adenocarcinoma Scirrhous carcinoma Carcinoma with ... Basophil adenocarcinoma Mucoid cell adenocarcinoma M8310/0 Clear cell adenoma M8310/3 Clear cell adenocarcinoma, NOS Clear cell ... Parietal cell adenocarcinoma M8215/3 Adenocarcinoma of anal glands (C21.1) Adenocarcinoma of anal ducts M8220/0 Adenomatous ... NOS M8210/3 Adenocarcinoma in adeonmatous polyp Adenocarcinoma in tubular adenoma Carcinoma in adeomatous polyp Adenocarcinoma ...
more infohttps://en.wikipedia.org/wiki/International_Classification_of_Diseases_for_Oncology
Forth dimention in kais village, Kullu - Book Appointment, View Contact Number, Feedbacks, Address | Dr. Sunil Fakay  Forth dimention in kais village, Kullu - Book Appointment, View Contact Number, Feedbacks, Address | Dr. Sunil Fakay
A typical carcinoma of the breast, that is, scirrhous adenocarcinoma, which begins in the ducts and ends in the parenchyma. As ... Non-small cell lung growths incorporate squamous cell carcinoma, adenocarcinoma and expansive cell carcinoma. ...
more infohttps://www.lybrate.com/kullu/clinic/forth-dimention-dhalpur-6c43
Fourth Dimension in Preet Vihar, Delhi - Book Appointment, View Contact Number, Feedbacks, Address | Dr. Sucharita Jain  Fourth Dimension in Preet Vihar, Delhi - Book Appointment, View Contact Number, Feedbacks, Address | Dr. Sucharita Jain
A typical carcinoma of the breast, that is, scirrhous adenocarcinoma, which begins in the ducts and ends in the parenchyma. As ... Non-small cell lung growths incorporate squamous cell carcinoma, adenocarcinoma and expansive cell carcinoma. ...
more infohttps://www.lybrate.com/delhi/clinic/fourth-dimension-preet-vihar
Charles Kwok Fai Chan | Stanford Medicine Profiles  Charles Kwok Fai Chan | Stanford Medicine Profiles
CUB-domain-containing protein 1 (CDCP1) was shown to promote metastasis in scirrhous and lung adenocarcinomas as well as in ...
more infohttps://med.stanford.edu/profiles/charles-chan
NAVER Academic > Search...  NAVER Academic > Search...
Adenocarcinoma, Scirrhous, pathology, Aged, Autopsy, Cecal Neoplasms, Diagnosis, Differential, Female, Goiter, Humans, Neoplasm ...
more infohttps://academic.naver.com/search.naver?field=3&query=New+England+journal+of+medicine+282%EA%B6%8C+4%ED%98%B8&page=2
gi [Nicks Radiology Wiki]  gi [Nick's Radiology Wiki]
usually related to a scirrhous gastric adenocarcinoma. +. * may also be seen in mets (especially breast cancer). ... metastatic disease from a mucinous adenocarcinoma or seminoma. +. * lymphoma can cause the findings of wall thickening, edema ... When present, especially in the sigmoid or descending colon, the main differential diagnosis is adenocarcinoma versus ... Klatskin tumor is usually the scirrhous type that grows along ducts and thickens their walls. ...
more infohttp://fasanonet.com/rad/doku.php?id=gi&rev=1499466609&do=diff
A typical carcinoma of the breast, that is, scirrhous adenocarcinoma, which begins in the ducts and ends in the parenchyma. As ...
more infohttps://ks-gopi.blogspot.com/2015/11/top-homoeopathic-remedies-for_24.html
  • Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line. (nih.gov)
  • S-1 plus cisplatin is the standard treatment for HER2-negative advanced scirrhous gastric cancer in Japan. (nih.gov)
  • In spite of recent advances in the treatment of gastric cancer, a standard chemotherapy regimen is yet to be established for scirrhous gastric cancer. (nih.gov)
  • These results suggest that combination treatment of chemotherapeutics with a fluoropyrimidine such as 5-FU is effective chemotherapy for scirrhous gastric cancer. (nih.gov)
  • To develop new therapeutic approaches based on characteristic biological features of cancer cells, we examined the mechanisms underlying the cytotoxicity of anticancer drugs and reactive oxygen species (ROS) toward a human scirrhous cancer cell line, HSC-39, in vitro. (nih.gov)